UArizona Researchers Develop Regenerative, Safe Therapeutic For Alzheimer's Disease

UArizona News
University of Arizona researchers led by Dr. Roberta Brinton have developed a new therapy for Alzheimer's disease designed to restore cognitive function in early-stage patients. The therapy is now proceeding through a Phase 2b clinical trial. The team has launched a startup, NeuTherapeutics Inc., to advance the technology toward making it available for patients.